INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
118 hedge funds and large institutions have $606M invested in Infinity Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
28% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 40
47% less call options, than puts
Call options by funds: $12.9M | Put options by funds: $24.2M
Holders
118
Holding in Top 10
1
Calls
$12.9M
Puts
$24.2M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$9.9M | |
| 3 | +$6.27M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.32M |
Top Sellers
| 1 | -$23M | |
| 2 | -$21.7M | |
| 3 | -$7.84M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$5.68M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.61M |